These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 28279508)

  • 1. Tuberculosis elimination and the challenge of latent tuberculosis.
    Matteelli A; Sulis G; Capone S; D'Ambrosio L; Migliori GB; Getahun H
    Presse Med; 2017 Mar; 46(2 Pt 2):e13-e21. PubMed ID: 28279508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
    Houben RM; Dodd PJ
    PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in diagnosis and treatment of latent tuberculosis infection.
    Chapman HJ; Lauzardo M
    J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of latent TB infection in areas of high TB prevalence.
    Sharma SK; Mohanan S; Sharma A
    Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National position statement for the management of latent tuberculosis infection.
    Stock D;
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying components for programmatic latent tuberculosis infection control in the European Union.
    Sandgren A; Vonk Noordegraaf-Schouten JM; Oordt-Speets AM; van Kessel GB; de Vlas SJ; van der Werf MJ
    Euro Surveill; 2016 Aug; 21(34):. PubMed ID: 27589214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries.
    Padmapriyadarsini C; Sachdeva KS; Nair D; Ramachandran R
    Expert Rev Respir Med; 2021 Jul; 15(7):899-910. PubMed ID: 33302729
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactivation tuberculosis: role of surveillance.
    DiNardo AR; Guy E
    Expert Rev Anti Infect Ther; 2016; 14(5):501-9. PubMed ID: 27042967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cursed duet today: Tuberculosis and HIV-coinfection.
    Tiberi S; Carvalho AC; Sulis G; Vaghela D; Rendon A; Mello FC; Rahman A; Matin N; Zumla A; Pontali E
    Presse Med; 2017 Mar; 46(2 Pt 2):e23-e39. PubMed ID: 28256380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Latent Tuberculosis Infection.
    Haley CA
    Microbiol Spectr; 2017 Apr; 5(2):. PubMed ID: 28409555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Compliance with latent tuberculosis treatment: a public health challenge].
    Bishara H; Ore L; Ravell DW
    Harefuah; 2014; 153(3-4):167-70, 239, 238. PubMed ID: 24791558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent tuberculosis infection: recent progress and challenges in South Korea.
    Jeon D
    Korean J Intern Med; 2020 Mar; 35(2):269-275. PubMed ID: 32131570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the risk factors for latent tuberculosis reactivation and their managements.
    Ai JW; Ruan QL; Liu QH; Zhang WH
    Emerg Microbes Infect; 2016 Feb; 5(2):e10. PubMed ID: 26839146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden.
    Mutsvangwa J; Millington KA; Chaka K; Mavhudzi T; Cheung YB; Mason PR; Butterworth AE; Corbett EL; Lalvani A
    Thorax; 2010 Apr; 65(4):315-20. PubMed ID: 20388756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons.
    Lee SS; Meintjes G; Kamarulzaman A; Leung CC
    Respirology; 2013 Aug; 18(6):912-22. PubMed ID: 23682586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis in the immigrant population in Italy: state-of-the-art review.
    Scotto G; Fazio V; Lo Muzio L
    Infez Med; 2017 Sep; 25(3):199-209. PubMed ID: 28956536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.